- Home
- GNTA vs YI Comparison
GNTA vs YI Comparison
Compare GNTA & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTA
- YI
- Stock Information
- Founded
- GNTA 2014
- YI 2010
- Country
- GNTA Italy
- YI China
- Employees
- GNTA N/A
- YI N/A
- Industry
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- GNTA Health Care
- YI Consumer Staples
- Exchange
- GNTA Nasdaq
- YI Nasdaq
- Market Cap
- GNTA 81.2M
- YI 70.0M
- IPO Year
- GNTA 2021
- YI N/A
- Fundamental
- Price
- GNTA $3.06
- YI $8.00
- Analyst Decision
- GNTA Strong Buy
- YI
- Analyst Count
- GNTA 1
- YI 0
- Target Price
- GNTA $25.00
- YI N/A
- AVG Volume (30 Days)
- GNTA 8.5K
- YI 11.5K
- Earning Date
- GNTA 01-01-0001
- YI 06-19-2025
- Dividend Yield
- GNTA N/A
- YI N/A
- EPS Growth
- GNTA N/A
- YI N/A
- EPS
- GNTA N/A
- YI N/A
- Revenue
- GNTA N/A
- YI $1,984,717,013.00
- Revenue This Year
- GNTA N/A
- YI N/A
- Revenue Next Year
- GNTA N/A
- YI N/A
- P/E Ratio
- GNTA N/A
- YI N/A
- Revenue Growth
- GNTA N/A
- YI N/A
- 52 Week Low
- GNTA $2.79
- YI $4.15
- 52 Week High
- GNTA $7.28
- YI $12.90
- Technical
- Relative Strength Index (RSI)
- GNTA 22.52
- YI 49.11
- Support Level
- GNTA $3.70
- YI $7.40
- Resistance Level
- GNTA $6.12
- YI $8.69
- Average True Range (ATR)
- GNTA 0.34
- YI 0.41
- MACD
- GNTA -0.14
- YI -0.02
- Stochastic Oscillator
- GNTA 0.33
- YI 46.51
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.